Trine Andersen1, Lea Munthe-Fog, Peter Garred, Søren Jacobsen. 1. Department of Clinical Immunology, University of Copenhagen, and Department of Rheumatology, The University Hospital of Copenhagen, Rigshospitalet, 4242, Blegdamsvej 9, Copenhagen, 2100, Denmark.
Abstract
OBJECTIVE: Ficolin-3 is a serum protein of putative importance in autoimmunity. Our objective was to investigate any differential expression of ficolin-3 in patients with systemic lupus erythematosus (SLE) or its clinical subsets. METHODS: Serum levels of ficolin-3 (S-ficolin-3) were determined in 95 patients with SLE and 103 healthy controls using an ELISA. RESULTS: Median S-ficolin-3 was 56.1 microg/ml (range 0 to >or=87.3) and 32.4 microg/ml (10 to >or=87.3) in patients and controls, respectively (p<0.001). Increased S-ficolin-3 was associated with hemolysis, positive Coombs test, and lymphopenia, but not with SLE Disease Activity Index scores or C-reactive protein. In one patient without detectable S-ficolin-3, the FCN3 gene appeared normal. CONCLUSION: The elevation of S-ficolin-3 and its association with specific manifestations in SLE may indicate a pathogenetic role of ficolin-3 in SLE.
OBJECTIVE:Ficolin-3 is a serum protein of putative importance in autoimmunity. Our objective was to investigate any differential expression of ficolin-3 in patients with systemic lupus erythematosus (SLE) or its clinical subsets. METHODS: Serum levels of ficolin-3 (S-ficolin-3) were determined in 95 patients with SLE and 103 healthy controls using an ELISA. RESULTS: Median S-ficolin-3 was 56.1 microg/ml (range 0 to >or=87.3) and 32.4 microg/ml (10 to >or=87.3) in patients and controls, respectively (p<0.001). Increased S-ficolin-3 was associated with hemolysis, positive Coombs test, and lymphopenia, but not with SLE Disease Activity Index scores or C-reactive protein. In one patient without detectable S-ficolin-3, the FCN3 gene appeared normal. CONCLUSION: The elevation of S-ficolin-3 and its association with specific manifestations in SLE may indicate a pathogenetic role of ficolin-3 in SLE.
Authors: Luis J Jara; Gabriela Medina; Pilar Cruz-Dominguez; Carmen Navarro; Olga Vera-Lastra; Miguel A Saavedra Journal: Immunol Res Date: 2014-12 Impact factor: 2.829
Authors: A Troldborg; S Thiel; L Jensen; S Hansen; M J Laska; B Deleuran; J C Jensenius; K Stengaard-Pedersen Journal: Clin Exp Immunol Date: 2015-08-31 Impact factor: 4.330
Authors: M-L Metzger; I Michelfelder; S Goldacker; K Melkaoui; J Litzman; D Guzman; B Grimbacher; U Salzer Journal: Clin Exp Immunol Date: 2015-02 Impact factor: 4.330
Authors: Anne Troldborg; Rudi Steffensen; Marten Trendelenburg; Thomas Hauser; Kasper G Winther; Annette G Hansen; Kristian Stengaard-Pedersen; Anne Voss; Steffen Thiel Journal: J Clin Immunol Date: 2019-05-01 Impact factor: 8.317
Authors: Agnieszka Szala; Sambor Sawicki; Anna St Swierzko; Janusz Szemraj; Marcin Sniadecki; Mateusz Michalski; Andrzej Kaluzynski; Jolanta Lukasiewicz; Anna Maciejewska; Dariusz Wydra; David C Kilpatrick; Misao Matsushita; Maciej Cedzynski Journal: Cancer Immunol Immunother Date: 2013-06-07 Impact factor: 6.968
Authors: Guilherme Ramires de Jesus; Claudia Mendoza-Pinto; Nilson Ramires de Jesus; Flávia Cunha Dos Santos; Evandro Mendes Klumb; Mario García Carrasco; Roger Abramino Levy Journal: Autoimmune Dis Date: 2015-07-12